Scott Tuten - 18 Apr 2022 Form 4 Insider Report for Danimer Scientific, Inc. (DNMR)

Role
Chief Marketing Officer
Signature
/s/ Scott Tuten
Issuer symbol
DNMR
Transactions as of
18 Apr 2022
Net transactions value
-$17,450
Form type
4
Filing time
20 Apr 2022, 16:09:26 UTC
Previous filing
21 Mar 2022
Next filing
19 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNMR Class A Common Stock ("Common Stock") Options Exercise $32,800 +10,000 +2% $3.28 514,136 18 Apr 2022 Direct F1
transaction DNMR Common Stock Sale $50,250 -10,000 -1.9% $5.02 504,136 18 Apr 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNMR Stock Option (right to purchase) Options Exercise $0 -10,000 -3.6% $0.000000 271,256 18 Apr 2022 Common Stock 10,000 $3.28 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 348,744 restricted shares of the Common Stock granted under a previously disclosed restricted stock award.
F2 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Tuten on June 25, 2021. The Reporting Person exercised no discretion with respect to the sale. Proceeds from the sale were used to pay the exercise price of stock options, pursuant to a broker-assisted cashless exercise, and applicable withholding taxes.
F3 The options are fully vested and currently exercisable.